🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07233629
Active, not recruiting Not applicable

M-TAPA vs RSB in Midline Abdominal Incision Laparotomy

NCT07233629 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2023-06-01
Last updated
2025-11-18

Condition(s) studied

Postoperative PainLaparotomy

Investigational drug(s) / intervention(s)

Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA)Rectus Sheath Block

Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA): 20 mL of 0.25% bupivacaine on each side

Rectus Sheath Block: 20 mL of 0.25% bupivacaine on each side

Study summary

The aim is to compare the postoperative analgesic effects of Modified ThoracoAbdominal nerve block through Perichondrial Approach (M-TAPA) versus Rectus Sheath Block (RSB) in patients undergoing laparotomy with midline abdominal incision.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: * Adult patients older than 18 years of age who underwent laparotomy with midline incision under general anesthesia and were American Society of Anesthesiologists (ASA) I-II-III according to the ASA risk classification. Exclusion Criteria: * patients who did not give consent, * patients with coagulopathy, * patients with signs of infection at the block application site, * patients using anticoagulants, * patients with local anesthetic drug allergies, * patients with unstable hemodynamics, * patients who could not cooperate during postoperative pain assessment * patients who received ileostomy or colostomy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sivas Cumhuriyet University Sivas Sivas

More Cumhuriyet University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07233629 on ClinicalTrials.gov ↗ ← All trials in Turkey